Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label, Uncontrolled Study to Investigate Suppression of Ovarian Activity of a Transdermal Contraceptive Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene in 80 Young Female Volunteers Over 3 Treatment Cycles

NCT02550977 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02550977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02550977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label, Uncontrolled Study to Investigate Suppression of Ovarian Activity of a Transdermal Contraceptive Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene in 80 Young Female Volunteers Over 3 Treatment Cycles
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
September 18, 2015
Completion date
August 15, 2016
Enrollment
91 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

contraception